The U.S. health care system lacks the capacity to rapidly move a treatment for Alzheimer’s disease from approval into wide clinical use, a shortcoming that could leave millions of people without access to transformative care if such a breakthrough occurs, according to a new RAND Corporation study.
from Dementia Big http://ift.tt/2juoNQ3 via alcoholic dementia
http://ift.tt/2A0xuZp
No comments:
Post a Comment